<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Media Release, Author at Lab 915 Technologies Inc</title>
	<atom:link href="https://lab915.com/author/media-release/feed/" rel="self" type="application/rss+xml" />
	<link>https://lab915.com/author/media-release/</link>
	<description>Plantar Fasciitis and Achilles Tendionpathy Treatment</description>
	<lastBuildDate>Thu, 01 Feb 2024 01:24:12 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
	<item>
		<title>Lab 915 Technologies Boosts Innovation Capacity via Mitacs Partnership</title>
		<link>https://lab915.com/2024/01/23/lab-915-technologies-boosts-innovation-capacity-via-mitacs-partnership/</link>
		
		<dc:creator><![CDATA[Media Release]]></dc:creator>
		<pubDate>Tue, 23 Jan 2024 23:37:21 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<guid isPermaLink="false">https://lab915.com/?p=202</guid>

					<description><![CDATA[<p>[FOR IMMEDIATE RELEASE: November 10, 2023] Vancouver, B.C. – Lab 915 Technologies Inc. is meeting the challenge of bringing new technologies to the assistive device market through the completion of a project in collaboration with British Columbia Institute of Technology’s Centre for Applied Research and Innovation MAKE+ Group, internship via Simon Fraser University, and funding [&#8230;]</p>
<p>The post <a href="https://lab915.com/2024/01/23/lab-915-technologies-boosts-innovation-capacity-via-mitacs-partnership/">Lab 915 Technologies Boosts Innovation Capacity via Mitacs Partnership</a> appeared first on <a href="https://lab915.com">Lab 915 Technologies Inc</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Lab 915 Technologies is Incorporated to Fulfill its Mission to Treat Plantar Fasciitis and Achilles Tendinopathy More Quickly and Easily</title>
		<link>https://lab915.com/2024/01/23/lab-915-technologies-is-incorporated-to-fulfill-its-mission-to-treat-plantar-fasciitis-and-achilles/</link>
		
		<dc:creator><![CDATA[Media Release]]></dc:creator>
		<pubDate>Tue, 23 Jan 2024 23:36:48 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<guid isPermaLink="false">https://lab915.com/?p=201</guid>

					<description><![CDATA[<p>[FOR IMMEDIAT RELEASE: February 18, 2023] Vancouver, B.C. – Lab 915 Technologies Inc. was incorporated on February 17, 2023, so that the company may develop novel medical technology to better treat plantar fasciitis and achilles tendinopathy.  The move unlocks access to various non-equity fundraising opportunities not limited to The National Research Council of Canada’s Industrial [&#8230;]</p>
<p>The post <a href="https://lab915.com/2024/01/23/lab-915-technologies-is-incorporated-to-fulfill-its-mission-to-treat-plantar-fasciitis-and-achilles/">Lab 915 Technologies is Incorporated to Fulfill its Mission to Treat Plantar Fasciitis and Achilles Tendinopathy More Quickly and Easily</a> appeared first on <a href="https://lab915.com">Lab 915 Technologies Inc</a>.</p>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
